Moneycontrol
HomeNewsBusinessCompaniesCOVID-19: Plan to sneak into office despite a fever? This technology won't let you
Trending Topics

COVID-19: Plan to sneak into office despite a fever? This technology won't let you

Ramco Innovation Lab has launched a technology where facial recognition plus thermal scanning could be automatically used to process the entry of employees into the workplace in the wake of the Coronavirus pandemic

March 18, 2020 / 20:17 IST
Story continues below Advertisement


Picture this. You are running a fever and yet, plan to quietly sneak into office anyway. Such plans could have worked earlier but may no longer be as simple amid paranoia over the spread of the deadly Coronavirus (COVID-19).

Some companies are now using automated systems such as facial recognition systems that are typically used at the entry gate to mark attendance as thermal sensors that detect body temperature also. If the temperature is above normal, the data is immediately relayed to the HR system and you may be mandatorily sent on leave.

Story continues below Advertisement

Offices with sliding doors may have the facial recognition attendance system linked to it. Anyone with above-normal body temperature will be denied access.

These technologies have been developed by Ramco Innovation Lab in Singapore in the wake of the COVID-19 pandemic. The lab, which is part of global enterprise software major Ramco Systems, unveiled a facial recognition-based Time & Attendance System – called RamcoGEEK.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show